June 11, 2026
Approximately 5 minutes
Reviewed by Nate Lam, Founder & Director, ElendiLabs
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
Registered Pharmacist · AI Engineer · Director, ElendiLabs
Registered pharmacist, AI engineer, HKHAIS founder, and pharmaceutical & medical device SEO/GEO specialist.
Ask Anything
We'll follow up with you personally.
100% response rate • Reply within 7 business days
Related Articles
Approximately 5 minutes
Bangladesh IVD Registration: DGDA Regulation and Reference Country Requirements
In Vitro Diagnostic (IVD) devices, including reagents, are regulated by the **DGDA** under the **Drugs and Cosmetics Act, 2023**. The registration process involves a mandatory **two-step review** for Class B, C, and D products, typically taking 4–6 months. Class C and D devices require a **Certificate of Free Sale (CFS)** and **ISO 13485** from a major Reference Country (EU, USA, Canada, Japan, Australia), while Class A/B only require a CFS from the country of origin.
Approximately 5 minutes
Bangladesh Medical Device Registration: DGDA Approval Process
Learn Bangladesh DGDA medical device registration, including the two-step approval process, labeling rules, and import requirements for manufacturers.
Approximately 5 minutes
Navigating the Kazakhstan Medical Device Market: National Pathway vs. EAEU Regulatory Compliance
An expert compliance blueprint for Kazakhstan and the Central Asia MedTech market for 2026. Meditor analyzes the indefinite validity of the National pathway before the 2027 deadline, Class 2A/2B registration costs, physical site audits, and CE mark advantages.